Almac IXRS (Interactive Response Technology) is the market-leading solution for Patient Randomisation and Trial Supply Management – with over 2,000 clinical trials successfully managed, and utilised at over 130,000 sites across the globe.
Almac Clinical Technologies are here to help the biopharmaceutical industry bring new therapies to those in need by empowering trial sponsors to proactively manage sites, patients, and clinical supplies through our industry-leading technology and expert consultancy.
The solutions we offer facilitate more than simplifying patient and trial material management – they engineer quality into the clinical trial process. Our technology provides sponsors and CROs with the visibility and control needed to make data-driven decisions by leveraging advanced supply management functionality coupled with real-time site and patient data in a closed-loop environment.
Almac is uniquely positioned to unlock new efficiency in the clinical supply chain, and to help achieve greater predictability in your projects and programs.
We employ more than 500 professionals dedicated to delivering high-quality solutions and reliable customer service. For nearly two decades, our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.
Contact us today to see how our technology will surpass your expectations, and experience how our seamless delivery will match your study-specifics regardless of size, phase, or complexity.
By the numbers
- Over 2,000 clinical trials performed with IXRS™
- Over 2 million patients supported
- Trials conducted in over 85 countries
- 65+ Language
- 10+ Rescue Studies
- 510 studies lasting 5+ years
- 115 studies lasting 4+ years
- 44 studies with over 500 sites
- 170 studies with 200 sites
- 55 studies with more than 5,000 patients
- 34 trials with 10,000+ patients
Providing unified distribution and supply strategies to manage and track the full life cycle and chain of custody of your IND / IMP while reducing risk and cost.
Electronic capture of patient data as reported in a clinical trial. Patient self-reported (ePRO), Clinician reported (ClinRO) or biomarker data is captured centrally for use in efficacy and safety study of the trial compound.
World-Class Biostatistical Services for patient randomisation methodologies, IXRS implementation and electronic clinical outcomes assessments (eCOA).
As a global leader in clinical supply chain Management, Almac offers a variety of services that help clients more efficiently manage clinical supplies around the world.